Your browser doesn't support javascript.
loading
Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design.
Viegas, Edna O; Kroidl, Arne; Munseri, Patricia J; Missanga, Marco; Nilsson, Charlotta; Tembe, Nelson; Bauer, Asli; Joachim, Agricola; Joseph, Sarah; Mann, Philipp; Geldmacher, Christof; Fleck, Sue; Stöhr, Wolfgang; Scarlatti, Gabriella; Aboud, Said; Bakari, Muhammad; Maboko, Leonard; Hoelscher, Michael; Wahren, Britta; Robb, Merlin L; Weber, Jonathan; McCormack, Sheena; Biberfeld, Gunnel; Jani, Ilesh V; Sandström, Eric; Lyamuya, Eligius.
Afiliação
  • Viegas EO; Instituto Nacional de Saúde (INS), Maputo, Mozambique.
  • Kroidl A; Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Germany.
  • Munseri PJ; German Centre for Infection Research (DZIF), partner site Munich, Munich, Germany.
  • Missanga M; Muhimbili University of Health and Allied Sciences (MUHAS), Department of Internal Medicine, Dar es Salaam, Tanzania.
  • Nilsson C; National Institute for Medical Research, Mbeya Medical Research Center (NIMR-MMRC), Mbeya, Tanzania.
  • Tembe N; Karolinska Institutet, Department of Laboratory Medicine, Huddinge, Sweden.
  • Bauer A; Public Health Agency of Sweden (PHAS), Department of Microbiology, Solna, Sweden.
  • Joachim A; Instituto Nacional de Saúde (INS), Maputo, Mozambique.
  • Joseph S; Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Germany.
  • Mann P; National Institute for Medical Research, Mbeya Medical Research Center (NIMR-MMRC), Mbeya, Tanzania.
  • Geldmacher C; Muhimbili University of Health and Allied Sciences (MUHAS), Department of Microbiology and Immunology, Dar es Salaam, Tanzania.
  • Fleck S; MRC Clinical Trials Unit at UCL, London, United Kingdom.
  • Stöhr W; Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Germany.
  • Scarlatti G; National Institute for Medical Research, Mbeya Medical Research Center (NIMR-MMRC), Mbeya, Tanzania.
  • Aboud S; Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Germany.
  • Bakari M; German Centre for Infection Research (DZIF), partner site Munich, Munich, Germany.
  • Maboko L; MRC Clinical Trials Unit at UCL, London, United Kingdom.
  • Hoelscher M; MRC Clinical Trials Unit at UCL, London, United Kingdom.
  • Wahren B; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), San Raffaele Scientific Institute, Viral Evolution and Transmission Unit, Milan, Italy.
  • Robb ML; Muhimbili University of Health and Allied Sciences (MUHAS), Department of Microbiology and Immunology, Dar es Salaam, Tanzania.
  • Weber J; Muhimbili University of Health and Allied Sciences (MUHAS), Department of Internal Medicine, Dar es Salaam, Tanzania.
  • McCormack S; National Institute for Medical Research, Mbeya Medical Research Center (NIMR-MMRC), Mbeya, Tanzania.
  • Biberfeld G; Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Germany.
  • Jani IV; German Centre for Infection Research (DZIF), partner site Munich, Munich, Germany.
  • Sandström E; Karolinska Institutet, Department of Microbiology, Tumor and Cell Biology, Stockholm, Sweden.
  • Lyamuya E; The US Military HIV Research Program, the Henry M Jackson Foundation for the Advancement of Military Medicine and Walter Reed Army Institute of Research, Silver Spring, MD, United States.
PLoS One ; 13(11): e0206838, 2018.
Article em En | MEDLINE | ID: mdl-30496299
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Virais / Infecções por HIV / Vacinas contra a AIDS / Vacinas de DNA / Imunogenicidade da Vacina Tipo de estudo: Clinical_trials País/Região como assunto: Africa Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Virais / Infecções por HIV / Vacinas contra a AIDS / Vacinas de DNA / Imunogenicidade da Vacina Tipo de estudo: Clinical_trials País/Região como assunto: Africa Idioma: En Ano de publicação: 2018 Tipo de documento: Article